Status:
UNKNOWN
Compliance of Diabetic Patients Treated With Metformin
Lead Sponsor:
Institute for Clinical and Experimental Medicine
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18+ years
Brief Summary
Metformin is the 1st line treatment in all subjects with type 2 diabetes without a contraindication to its use. The compliance with the use of metformin is not optimal mainly owing to relatively frequ...
Eligibility Criteria
Inclusion
- Type 2 diabetes mellitus on metformin therapy for at least 3 months
Exclusion
- \-
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03864705
Start Date
March 1 2019
End Date
December 31 2021
Last Update
September 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Clinical and Experimental Medicine
Prague, Czechia, 14021